Allied Stock Price, News & Analysis
Company Description
Allied (OTC Link: ALID) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $1.3M.
ALID stock has declined 100.0% over the past year. Shares last traded at $0.0000.
On a trailing twelve-month basis, Allied reported revenue of $96K with net income of -$4.0M and diluted earnings per share of $-0.04. The company operates at a net profit margin of -4134.1%.
This page provides a comprehensive overview of ALID stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Allied (ALID) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.3M, ALID is classified as a micro-cap stock with approximately 115.5M shares outstanding.
Latest News
Allied has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. View all ALID news →
SEC Filings
Financial Highlights
Allied generated $96K in revenue over the trailing twelve months, retaining a -336.0% gross margin, operating income reached -$4.0M (-4134.1% operating margin), and net income was -$4.0M, reflecting a -4134.1% net profit margin. Diluted earnings per share stood at $-0.04. The company generated -$2.0M in operating cash flow. With a current ratio of 0.07, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
ALID Company Profile & Sector Positioning
Allied (ALID) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ALID often look at related companies in the same sector, including Panacea Life Sciences Hldgs Inc (PLSH), Acura Pharm (ACUR), Nunzia Pharmaceutical Corp (NUNZ), Cbd Life Science (CBDL), and Genix Pharmaceut (GENPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ALID's relative position within its industry.